The role of endothelial connexins in vascular wound repair
内皮连接蛋白在血管伤口修复中的作用
基本信息
- 批准号:10751730
- 负责人:
- 金额:$ 4.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-10 至 2026-02-09
- 项目状态:未结题
- 来源:
- 关键词:AlanineAntibodiesAortaAreaArteriesBiologicalBiologyBiomedical ResearchBlood VesselsC-terminalCarotid ArteriesCell CommunicationCell Culture TechniquesCell LineCell ProliferationCell SeparationCellsCessation of lifeCommunicationConfocal MicroscopyConnexin 43ConnexinsCoronary ThrombosisCoronary arteryDataData AnalysesDefectDeoxyuridineDiseaseEndothelial CellsEndotheliumEnsureEnvironmentEquipmentFailureFellowshipFemaleGap JunctionsGeneticGoalsHealthHeartHomeHourHumanImmunofluorescence ImmunologicImpaired healingImpairmentInjectionsInjuryInvestigationKnock-outKnockout MiceLegal patentLifeLigationLinkMeasuresMediatingMentorshipMicroscopeMissionModelingModernizationModificationMusMutationMyocardial InfarctionOperative Surgical ProceduresPathway interactionsPatientsPharmaceutical PreparationsPhosphorylationPhosphorylation InhibitionPhosphorylation SitePhosphotransferasesPlasmidsPost-Translational Protein ProcessingPreparationProcessProliferatingProliferation MarkerProto-Oncogene Proteins c-aktResearchResearch InstituteResearch PersonnelRoleSaphenous VeinSerineSignal PathwaySignal TransductionSiteStentsSurvival RateTechnical ExpertiseTechniquesTestingTherapeuticThrombusTissuesTrainingTransfectionTravelUnited States National Institutes of HealthUniversitiesUp-RegulationVascular DiseasesVascular Endothelial CellVascular GraftVirginiaWestern BlottingWorkanimal facilityburden of illnesscell growthcell injurycell motilitydesignendothelial regenerationendothelial repairexperienceexperimental studyhealingimprovedin vivoin vivo Modelinjuredmalemigrationmimeticsnovelpharmacologicprotein expressionrepairedresponserestenosissexstroke risktherapeutic targettranscriptome sequencingvascular injurywound closurewound healing
项目摘要
|| Project Summary .
Impaired endothelial wound healing in blood vessels like the coronary artery and saphenous vein is a primary
contributor to vascular stent failure and deadly coronary thrombosis. Identifying the mechanism of delayed
endothelial repair is essential for improving vessel patency and patient survival rates. As such, this proposal
focuses on identifying regulators of normal endothelial healing and understanding how these factors are
dysregulated when healing is impaired. Previous studies have shown connexin 43 (Cx43) gap junctions may
regulate wound healing. However, the specific role of connexin 43 in endothelial cell (EC) healing is unknown.
Preliminary data in this proposal indicates that ligation-induced vascular injury promotes increases in the
expression of EC Cx43 surrounding the damaged area in the aorta and carotid arteries in mice. Cx43-mediated
gap junction intracellular communication is controlled by phosphorylation at the Cx43 C-terminus. My preliminary
data demonstrate that specific Cx43 phosphorylation at its serine (s) 368, associated with gap junction closure,
is present during the final stages of EC wound healing in vivo. Cx43-s368 also reduced the rate of wound closure
in cultured human EC. These findings inform the hypothesis that Cx43 expression and channel functions are
critical for EC wound healing in large arteries. The aims of this proposal are to define the role of connexin 43 in
endothelial wound healing (Aim 1), investigate if a loss of Cx43 limits healing in vivo (Aim 1), and test if channel
functions, regulated by posttranslational modifications, improve/delay vascular repair (Aim 2). This investigation
will be completed using a novel mouse carotid EC injury survival surgery in mice I developed, which will allow
for the assessment of Cx43 expression in carotid EC during the healing process. Both genetic and
pharmacological strategies will be used to alter Cx43 expression and phosphorylation in mouse injury models
and in cultured human EC, and the impact of these modifications on the rate and quality of EC healing will be
quantified. Additionally, RNAseq approaches will be used to identify Cx43 gap junction-dependent signaling in
the regenerating endothelium. These aims will be accomplished under the mentorship of researchers with
extensive experience in vascular biology, Dr. Scott Johnstone, Dr. Robert Gourdie, and Dr. Brant Isakson, at
Virginia Tech’s Fralin Biomedical Research Institute (FBRI). The FBRI is home to research equipment including
but not limited to animal facilities, confocal microscopes, flow cytometers, and cell culture equipment. This state-
of-the-art research environment will allow for a detailed and mechanistic investigation. Ultimately, this study will
characterize a novel role for Cx43 in vascular EC. This project is designed to identify new potential therapeutic
targets in vascular disease that will promote the mission of the NIH to enhance patient health and to promote
longer life free of illness.
||项目摘要。
冠状动脉和隐静脉等血管中的内皮伤口愈合受损是主要的
血管支架衰竭和致命冠状动脉血栓形成的贡献者。识别延迟的机制
内皮修复对于提高血管通畅和患者存活率至关重要。因此,这个建议
专注于确定正常内皮愈合的调节因子,并了解这些因素的状况如何
治愈受损时失调。先前的研究表明连接蛋白43(CX43)间隙连接可能
调节伤口愈合。但是,连接蛋白43在内皮细胞(EC)愈合中的特定作用尚不清楚。
该提案中的初步数据表明,结扎引起的血管损伤促进
小鼠主动脉和颈动脉受损区域周围的EC CX43的表达。 CX43介导的
间隙连接在CX43 C端的磷酸化控制。我的初步
数据表明,在其丝氨酸368处的特定CX43磷酸化,与间隙连接闭合相关,
在体内EC伤口愈合的最后阶段存在。 CX43-S368还降低了伤口闭合率
在文化的人类EC中。这些发现告知了CX43表达和通道功能的假设
对于大动脉的EC伤口愈合至关重要。该提议的目的是确定连接蛋白43在
内皮伤口愈合(AIM 1),研究CX43的损失是否限制了体内愈合(AIM 1),并测试是否通道
受翻译后修饰调节的功能改善/延迟血管修复(AIM 2)。这项投资
将使用我开发的小鼠中的新型小鼠颈动脉EC损伤手术完成,这将允许
为了评估康复过程中颈动脉EC中CX43表达的表达。遗传和
药理策略将用于改变小鼠损伤模型中的CX43表达和磷酸化
在文化的人类EC中,这些修饰对EC治疗的速度和质量的影响将是
量化。此外,RNASEQ方法将用于识别CX43间隙连接依赖性信号传导
再生内皮。这些目标将在研究人员的指导下实现
在血管生物学方面的丰富经验,Scott Johnstone博士,Robert Gourdie博士和Brant Isakson博士,AT
弗吉尼亚理工大学的弗拉林生物医学研究所(FBRI)。 FBRI是研究设备的家园
但不限于动物设施,共聚焦显微镜,流式细胞仪和细胞培养设备。这个国家 -
艺术研究环境将允许进行详细的机械投资。最终,这项研究将
表征CX43在血管EC中的新作用。该项目旨在确定新的潜在疗法
血管疾病的靶标将促进NIH的使命,以增强患者健康并促进
长寿没有疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Meghan Sedovy其他文献
Meghan Sedovy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Vascular Pathophysiology and History Core (VPHC)
血管病理生理学和病史核心 (VPHC)
- 批准号:
7662920 - 财政年份:2009
- 资助金额:
$ 4.25万 - 项目类别:
Therapeutic Modulation of Endothelial Cell Tetrahydrobiopterin
内皮细胞四氢生物蝶呤的治疗调节
- 批准号:
8379505 - 财政年份:
- 资助金额:
$ 4.25万 - 项目类别: